oseltamivir has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chiu, CC; Hsiao, MH; Hsu, TC; Huang, PJ; Tzang, BS; Yow, JL | 1 |
Barros, R; de Matos, AJ; de Oliveira, JT; Gärtner, F; Gomes, C; Mendes, N; Oliveira, MJ; Reis, CA; Ribeiro, C; Santos, AL; Vasconcelos, MH | 1 |
2 other study(ies) available for oseltamivir and Invasiveness, Neoplasm
Article | Year |
---|---|
Potential of antiviral drug oseltamivir for the treatment of liver cancer.
Topics: Animals; Antiviral Agents; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Proliferation; Female; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Oseltamivir; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Dogs; Enzyme Inhibitors; Female; Immunoenzyme Techniques; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Nude; Neoplasm Invasiveness; Neuraminidase; Oseltamivir; Tumor Cells, Cultured; Wound Healing; Xenograft Model Antitumor Assays | 2015 |